Government ❯Health Policy ❯NHS
Pharmaceutical Investments Pharmaceuticals Drug Trials Healthcare Investment 10-Year Plan Waiting Times
The upcoming 10-year strategy features a £650 million genomics investment to screen every newborn as the NHS shifts toward predictive prevention.